Fundraiser Manny Singh Kang has begun another fundraising challenge, a challenge which will see him ride non-stop for 24 hours on a static bike outside Wolverhampton University UK wins bid to overturn ...
Hernexeos is the first oral targeted therapy for HER2-mutant NSCLC, offering a new treatment option for patients with limited alternatives. The Beamion-LUNG 1 trial showed a 75% objective response ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
Master the art of using Generative Fill on non-static video footage with After Effects. This tutorial covers essential techniques to handle moving subjects, track motion, and apply AI-powered fills ...
Thoracic medical oncologists and early drug development specialists at Memorial Sloan Kettering Cancer Center (MSK) continue to investigate new ways to improve outcomes for this patient population.
Introduction Ischaemia–reperfusion (I/R) injury remains a major challenge in heart transplantation, with mortality risk increasing significantly when allograft ischaemic time exceeds 4 hours.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback